A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
Clinical trial NCT06387420 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06387420
- Sponsor
- Akeso
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-29
- Primary completion
- 2026-04-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.